Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume 41, Issue 6, Pages 594-616Publisher
PHARMACEUTICAL SOC KOREA
DOI: 10.1007/s12272-018-1038-y
Keywords
Pro-apoptotic peptides; Cancer; Anti-cancer drugs; Molecular approaches; Nanoparticles
Categories
Funding
- Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2015R1C1A1A02036781, NRF-2017R1C1B5015491]
Ask authors/readers for more resources
Cancer is a leading cause of death worldwide. Despite many advances in the field of cancer therapy, an effective cure is yet to be found. As a more potent alternative for the conventional small molecule anti-cancer drugs, pro-apoptotic peptides have emerged as a new class of anticancer agents. By interaction with certain members in the apoptotic pathways, they could effectively kill tumor cells. However, there remain bottleneck challenges for clinical application of these pro-apoptotic peptides in cancer therapy. In this review, we will overview the developed pro-apoptotic peptides and outline the widely adopted molecular-based and nanoparticle-based strategies to enhance their anti-tumor effects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available